Inventor
BALLENTINE SHELLEY K
US20 patents
⚠️ This page may combine multiple inventors who share the name “BALLENTINE SHELLEY K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
13 patentsUS7973035B2Jul 5, 2011
Inhibitors of C-FMS kinase
JANSSEN PHARMACEUTICA NV24 citations92
US7795279B2Sep 14, 2010
Method of inhibiting FLT3 kinase
JANSSEN PHARMACEUTICA NV30 citations92
US7662837B2Feb 16, 2010
Inhibitors of c-fms kinase
JANSSEN PHARMACEUTICA NV26 citations91
US7645755B2Jan 12, 2010
Inhibitors of c-fms kinase
JANSSEN PHARMACEUTICA NV45 citations91
US8895584B2Nov 25, 2014
Inhibitors of c-fms kinase
JANSSEN PHARMACEUTICA NV4 citations84
US9296726B2Mar 29, 2016
Inhibitors of c-fms kinase
JANSSEN PHARMACEUTICA NV2 citations62
US9221797B2Dec 29, 2015
Inhibitors of c-fms kinase
JANSSEN PHARMACEUTICA NV2 citations62
US7705042B2Apr 27, 2010
Class of arylamide compounds useful as inhibitors of c-fms kinase
JANSSEN PHARMACEUTICA NV3 citations60
US9452996B2Sep 27, 2016
Inhibitors of c-fms kinase
JANSSEN PHARMACEUTICA NV0 citations52
US9403804B2Aug 2, 2016
Inhibitors of c-fms kinase
JANSSEN PHARMACEUTICA NV0 citations52
US9394289B2Jul 19, 2016
Inhibitors of c-fms kinase
JANSSEN PHARMACEUTICA NV0 citations52
US9526731B2Dec 27, 2016
Method of inhibiting C-KIT kinase
JANSSEN PHARMACEUTICA NV0 citations50
US8933091B2Jan 13, 2015
Method of inhibiting C-KIT kinase
JANSSEN PHARMACEUTICA NV0 citations50
ILLIG CARL R
4 patentsDIMENSIONAL PHARM INC
2 patentsUS7109354B2Sep 19, 2006
Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
DIMENSIONAL PHARM INC17 citations91
US7138530B2Nov 21, 2006
Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
DIMENSIONAL PHARM INC29 citations90